ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FC01 | BioTech | Daratumumab - 100mg/5ml | 8900/945 | 166916/1 | DARZALEX | 100mg/5ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Cilag AG | Switzerland | 45,091,167 L.L | 10.71 | E1 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FC01 | BioTech | Daratumumab - 100mg/5ml | 8900 | 166916/1 | DARZALEX | 100mg/5ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Cilag AG | Switzerland | 739,604 L.L | 10.71 | E1 | Janssen Cilag International NV | Belgium | 2/5/2024 |